Cargando…
An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
Respiratory syncytial virus (RSV) can cause severe respiratory disease in humans, particularly in infants and the elderly. However, attempts to develop a safe and effective vaccine have so far been unsuccessful. Atomic-level structures of epitopes targeted by RSV-neutralizing antibodies are now know...
Autores principales: | Zuniga, Armando, Rassek, Oliver, Vrohlings, Melissa, Marrero-Nodarse, Aniebrys, Moehle, Kerstin, Robinson, John A., Ghasparian, Arin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213762/ https://www.ncbi.nlm.nih.gov/pubmed/34145291 http://dx.doi.org/10.1038/s41541-021-00347-y |
Ejemplares similares
-
Author Correction: An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
por: Zuniga, Armando, et al.
Publicado: (2021) -
A Synthetic Virus-Like Particle Streptococcal Vaccine Candidate Using B-Cell Epitopes from the Proline-Rich Region of Pneumococcal Surface Protein A
por: Tamborrini, Marco, et al.
Publicado: (2015) -
Synthetic Virus-Like Particles Target Dendritic Cell Lipid Rafts for Rapid Endocytosis Primarily but Not Exclusively by Macropinocytosis
por: Sharma, Rajni, et al.
Publicado: (2012) -
Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013) -
Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study
por: Terletskaia-Ladwig, Elena, et al.
Publicado: (2005)